Is Dual Therapy With Raltegravir and Protease Inhibitors a Feasible Option in Rescue Strategy in HIV-1 Infection?

被引：14
作者：
Capetti, Amedeo Ferdinando [1 ]
Piconi, Stefania [1 ]
Landonio, Simona [1 ]
Rizzardini, Giuliano [1 ]
Perno, Carlo Federico [2 ]
机构：
[1] Luigi Sacco Hosp, Div Infect Dis 1, Milan, Italy
[2] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Rome, Italy
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2009年 / 50卷 / 02期
关键词：
RANDOMIZED CONTROLLED-TRIAL; EFFICACY; REGIMEN;
D O I：
10.1097/QAI.0b013e31818c7e8e
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：233 / 234
页数：2
相关论文
共 7 条
[1]   Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection [J].
Anderson, Jeffrey A. ;
Jiang, Hongyu ;
Ding, Xiao ;
Petch, Leslie ;
Journigan, Terri ;
Fiscus, Susan A. ;
Haubrich, Richard ;
Katzenstein, David ;
Swanstrom, Ronald ;
Gulick, Roy M. .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (05) :685-694
[2]   Resistance profile of darunavir:: Combined 24-week results from the POWER trials [J].
de Meyer, Sandra ;
Vangeneugden, Tony ;
van Baelen, Ben ;
de Paepe, Els ;
van Marck, Herwig ;
Picchio, Gaston ;
Lefebvre, Eric ;
de Bethune, Marie-Pierre .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (03) :379-388
[3]   Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial [J].
Grinsztejn, Beatriz ;
Nguyen, Bach-Yen ;
Katlama, Christine ;
Gatell, Jose M. ;
Lazzarin, Adriano ;
Vittecoq, Daniel ;
Gonzalez, Charles J. ;
Chen, Joshua ;
Harvey, Charlotte M. ;
Isaacs, Robin D. .
LANCET, 2007, 369 (9569) :1261-1269
[4]   Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection - A randomized controlled trial [J].
Gulick, Roy M. ;
Ribaudo, Heather J. ;
Shikuma, Cecilia M. ;
Lalama, Christina ;
Schackman, Bruce R. ;
Meyer, William A., III ;
Acosta, Edward P. ;
Schouten, Jeffrey ;
Squires, Kathleen E. ;
Pilcher, Christopher D. ;
Murphy, Robert L. ;
Koletar, Susan L. ;
Carlson, Margrit ;
Reichman, Richard C. ;
Bastow, Barbara ;
Klingman, Karin L. ;
Kuritzkes, Daniel R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (07) :769-781
[5]   Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 clinical trials [J].
Nelson, M ;
Arastéh, K ;
Clotet, B ;
Cooper, DA ;
Henry, K ;
Katlama, C ;
Lalezari, JP ;
Lazzarin, A ;
Montaner, JSG ;
O'Hearn, M ;
Piliero, PJ ;
Reynes, J ;
Trottier, B ;
Walmsley, SL ;
Cohen, C ;
Eron, JJ ;
Kuritzkes, DR ;
Lange, J ;
Stellbrink, HJ ;
Delfraissy, JF ;
Buss, NE ;
Donatacci, L ;
Wat, C ;
Smiley, L ;
Wilkinson, M ;
Valentine, A ;
Guimaraes, D ;
DeMasi, R ;
Chung, J ;
Salgo, MP .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (04) :404-412
[6]   Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults [J].
Staszewski, S ;
Morales-Ramirez, J ;
Tashima, KT ;
Rachlis, A ;
Skiest, D ;
Stanford, J ;
Stryker, R ;
Johnson, P ;
Labriola, DF ;
Farina, D ;
Manion, DJ ;
Ruiz, NM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1865-1873
[7]   Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels - Results of a prospective randomized trial (AIDS clinical trial group 5725s) [J].
Tebas, Pablo ;
Zhang, Jiameng ;
Yarasheski, Kevin ;
Evans, Scott ;
Fischl, Margaret A. ;
Shevitz, Abby ;
Feinberg, Judith ;
Collier, Ann C. ;
Shikuma, Cecilia ;
Brizz, Barbara ;
Sattler, Fred .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (02) :193-200
1